Inovio Pharma (INO) Reports Q2 Loss of $0.83/sh
Tweet
Share
E-mailGet Alerts INO Hot Sheet
Price: $9.68 -5.1%
EPS Growth %: -625.0%
Financial Fact:
Total operating expenses: 32.74M
Today's EPS Names:
MAXN, CSTR, ACU, More
EPS Growth %: -625.0%
Financial Fact:
Total operating expenses: 32.74M
Today's EPS Names:
MAXN, CSTR, ACU, More
Join SI Premium – FREE
Inovio Pharma (NASDAQ: INO) reported Q2 EPS of ($0.83), versus ($0.30) reported last year. Revenue for the quarter came in at $237 thousand, versus $135.7 thousand reported last year.
For earnings history and earnings-related data on Inovio Pharma (INO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Growth isn't weak enough to truly undercut inflation pressures - BMO
- Super Micro Computer (SMCI) Falls 6%
- Safe & Green (SGBX) Provides Update on Audit and Planned 10-K Filing
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
